Jim Simons Lyra Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 50,900 shares of LYRA stock, worth $13,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,900

Previous 43,900 15.95%

Holding current value

$13,743

Previous $230,000 37.83%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.55 - $6.53 $31,850 - $45,710	7,000 Added 15.95%	50,900 $317,000
Q4 2023 Feb 13, 2024	SELL	$2.82 - $5.24 $16,638 - $30,916	-5,900 Reduced 11.85%	43,900 $230,000
Q3 2023 Nov 14, 2023	SELL	$2.95 - $4.8 $62,540 - $101,760	-21,200 Reduced 29.86%	49,800 $195,000
Q2 2023 Aug 11, 2023	BUY	$1.98 - $4.33 $45,835 - $100,235	23,149 Added 48.38%	71,000 $292,000
Q1 2023 May 12, 2023	BUY	$1.95 - $3.09 $20,769 - $32,911	10,651 Added 28.63%	47,851 $96,000

Q4 2022 Feb 13, 2023	SELL	$2.44 - $4.92 $6,832 - $13,776	-2,800 Reduced 7.0%	37,200 $117,000
Q3 2022 Nov 14, 2022	SELL	$5.33 - $6.6 $5,330 - $6,600	-1,000 Reduced 2.44%	40,000 $200,000
Q2 2022 Aug 12, 2022	BUY	$4.12 - $7.51 $96,820 - $176,485	23,500 Added 134.29%	41,000 $232,000
Q1 2022 May 13, 2022	SELL	$3.5 - $5.36 $120,750 - $184,920	-34,500 Reduced 66.35%	17,500 $70,000
Q4 2021 Feb 11, 2022	BUY	$4.22 - $9.41 $219,440 - $489,320	52,000 New	52,000 $227,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

44.4M

Call Options Held

300K

Put Options Held

1.3K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.59M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account